View in EDS

Review - The impact of pharmacogenetics on the outcome of immune checkpoint inhibitors.

Saved in:
Bibliographic Details
Title: Review - The impact of pharmacogenetics on the outcome of immune checkpoint inhibitors.
Authors: de Joode K; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Heersche N; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Clinical Chemistry, Erasmus MC, Erasmus University Hospital, Rotterdam, the Netherlands., Basak EA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Radiology & Nuclear Medicine, Erasmus MC, Erasmus University Hospital, Rotterdam, the Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus MC, Erasmus University Hospital, Rotterdam, the Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: a.mathijssen@erasmusmc.nl.
Source: Cancer treatment reviews [Cancer Treat Rev] 2024 Jan; Vol. 122, pp. 102662. Date of Electronic Publication: 2023 Nov 27.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38043396
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Review - The impact of pharmacogenetics on the outcome of immune checkpoint inhibitors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22de+Joode+K%22">de Joode K</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Heersche+N%22">Heersche N</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Clinical Chemistry, Erasmus MC, Erasmus University Hospital, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Basak+EA%22">Basak EA</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Bins+S%22">Bins S</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Veldt+AAM%22">van der Veldt AAM</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Radiology & Nuclear Medicine, Erasmus MC, Erasmus University Hospital, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Schaik+RHN%22">van Schaik RHN</searchLink>; Department of Clinical Chemistry, Erasmus MC, Erasmus University Hospital, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Mathijssen+RHJ%22">Mathijssen RHJ</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: a.mathijssen@erasmusmc.nl.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227502030%22">Cancer treatment reviews</searchLink> [Cancer Treat Rev] 2024 Jan; Vol. 122, pp. 102662. <i>Date of Electronic Publication: </i>2023 Nov 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>7502030 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1967 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203057372%22">03057372 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Treat Rev <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38043396
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ctrv.2023.102662
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102662
    Titles:
      – TitleFull: Review - The impact of pharmacogenetics on the outcome of immune checkpoint inhibitors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: de Joode K
      – PersonEntity:
          Name:
            NameFull: Heersche N
      – PersonEntity:
          Name:
            NameFull: Basak EA
      – PersonEntity:
          Name:
            NameFull: Bins S
      – PersonEntity:
          Name:
            NameFull: van der Veldt AAM
      – PersonEntity:
          Name:
            NameFull: van Schaik RHN
      – PersonEntity:
          Name:
            NameFull: Mathijssen RHJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2024 Jan
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1532-1967
          Numbering:
            – Type: volume
              Value: 122
          Titles:
            – TitleFull: Cancer treatment reviews
              Type: main
ResultId 1